NYC startup
fromTechCrunch
3 months agoExclusive: Ataraxis AI raises $20.4 million Series A to personalize cancer treatment
Ataraxis AI aims to revolutionize cancer treatment decisions by predicting long-term outcomes, potentially reducing unnecessary chemotherapy.